...
机译:人子宫内膜间充质细胞中的血清非依赖性心肌转分化。
Department of Cardiology, Keio University School of Medicine;
|Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
|Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine;
Department of Cardiology, Keio University School of Medicine;
|Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
Department of Cardiology, Keio University School of Medicine;
|Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
|Department of Cardiovascular Surgery, Keio University School of Medicine;
and;
Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan;
Department of Cardiology, Keio University School of Medicine;
Department of Reproductive Biology and Pathology, National Research Institute for Child Health and Development;
Cardiomyogenesis; Human mesenchymal stem cells; Serum free; Assay system; Cardiomyogenic factors;
机译:人子宫内膜间充质细胞中的血清非依赖性心肌原性转分化。
机译:用血管紧张素受体阻滞剂治疗人间充质干细胞可提高心肌转分化的效率,并通过血管生成改善心脏功能。
机译:吡格列酮预处理人间充质干细胞可改善心肌成因分化和心脏功能的效率。
机译:使用生物印染的支架将人间充质干细胞从3D转分化为类肝细胞
机译:人多能干细胞引起心肌病的几何控制。
机译:骨髓来源的人间充质干细胞表达心肌生成蛋白但不具有功能性心肌生成分化潜能
机译:血管紧张素受体阻滞剂改善了人骨髓间充质干细胞的心血管转化分化效率